Theseus Pharmaceuticals, Inc. THRX
4.07 0.00 (+0.00%)
Feb 13, 2024, 3:59 PM EST
4.06 Day range 4.07
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 5.25 +29.2% upside
Now 4.07
- Target (low)
- 3.50
- Target (mean)
- 5.25
- Target (high)
- 7.00
Ratings (-1m) 3 1 buy · 2 hold · 0 sell
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 3
- 2 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.29 | -0.29 – -0.29 | -0.35 | +17.1% | 0 | 0.0% | 1 |
| Next quarter | -0.44 | -0.44 – -0.44 | -0.34 | -29.4% | 0 | 0.0% | 1 |
| Current year | -1.28 | -1.28 – -1.28 | -1.31 | +2.3% | 0 | 0.0% | 1 |
| Next year | -1.07 | -1.07 – -1.07 | -1.28 | +16.4% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 13, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jul 13, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Jul 13, 2023 | Needham | Downgrade | Buy | Hold |
| Jul 13, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 25, 2023 | Needham | Reiterated | Buy | Buy |
| May 25, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2023 | Needham | Reiterated | Buy | Buy |
| May 11, 2023 | Needham | Reiterated | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 15, 2023 | Stifel | Initiated | — | Buy |
| Mar 9, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 9, 2023 | Needham | Reiterated | — | Buy |
| Dec 13, 2022 | Needham | Initiated | — | Buy |
| Jun 29, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 31, 2021 | Jefferies | Initiated | — | Buy |
| Oct 31, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |
| Oct 31, 2021 | Wedbush | Initiated | — | Outperform |
| Oct 31, 2021 | SVB Leerink | Initiated | — | Outperform |
